Objective Biologics for systemic lupus erythematosus (SLE) demonstrate variable treatment responses across trials. We evaluated baseline biomarkers as predictors of response to guide personalised ...
The moment a system stops explaining and starts commanding, it becomes a bureaucrat. Corporate history is littered with ...
Valued at $1.6 billion, a tiny start-up called Axiom is building A.I. systems that can check for mistakes. By Cade Metz Following rivals like Amazon and OpenAI, Microsoft is upgrading its artificially ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results